|
| |
Image Results
Loading...
Loading...
Celgene Pages on BioPortfolio:
|
Biotechnology News THALOMID Search
t 8:02 AM Comments (0) Print view Share Biotech drugmaker Celgene Corp. ... Celgene Reports Record Third Quarter 2009 Operating and Financial Results ...
http://www.bioportfolio.co.uk/THALOMID-news.htm...
|
BioTech Sage Report - ReCap on BioGen, Celgene, ICOS, Genzyme, Imclone
Second, Celgene announced that the company would acquire Anthrogenesis for ... This deal may prove to be a very lucrative for Celgene as the company plans ...
http://www.bioportfolio.com/news/biotechsage_1.htm...
|
Biotechnology News Arthritis Psoriatic Search
Celgene Corporation (NASDAQ: CELG) announced that updated results of a ... Celgene Says Psoriatic Arthritis Drug Demonstrated Sustained Response At Six ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
Celgene Corporation: PharmaVitae Profile
Celgene Corporation: PharmaVitae Profile Company Report CSHC1432.
http://www.bioportfolio.com/cgi-bin/acatalog/Celgene-Corpora...
|
Biotechnology News protein characterization deterg. e2. apl. drm ...
Celgene Corporation (NASDAQ: CELG) today announced that clinical investigators from leading hematology research centers around the world will present data ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Celgene Corporation - Profile
View the current Celgene Corporation Page on BioPortfolio.com ... Department of Immunotherapeutics, Celgene Corporation, 86 Morris Avenue,- Microvasc Res. ...
http://www.bioportfolio.com/biocorporate/466-Celgene%2BCorpo...
|
Biotechnology News primecap. fedex. 009. guru. vanguard. numvis ...
22 Nov 2009 ... BiomedReports: News and FDA Updates for Celgene (NASDAQ:), Genzyme (Nasdaq:) Monday November 16, 009 04:00:16 EST Pasadena, CA, Nov 16, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
| Results from other life science and pharmaceutical sites:
Celgene - Wikipedia, the free encyclopedia
Celgene Corporation (NASDAQ: CELG) is a manufacturer of drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and ...
http://en.wikipedia.org/wiki/Celgene...
|
BioSpace - Celgene News, Search Jobs, Events
Company Profile. Celgene 4550 Towne Centre Court San Diego California 92121 U.S.A.. Phone: 858-558-7500 Fax: 858-552-8775. SEARCH JOBS. Key Statistics ...
http://www.biospace.com/company_profile.aspx?CompanyId=1908...
|
Celgene Corporation - Google Finance
Get the latest on Celgene Corporation including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:CELG...
|
VIDAZA (azacitidine) injection [Celgene Corporation] - DailyMed ...
To report SUSPECTED ADVERSE REACTIONS, contact Celgene Corporation at 1-888-423- 5436 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8455...
|
Ligand Collaborations
The research phase of the collaboration is complete and Celgene is solely responsible for the funding and management of development ...
http://www.pharmacopeia.com/collaborations.php...
|
News: Celgene and Innate Collaborate on Trial Combining Their ...
18 Nov 2009 ... Revlimid and IPH 2101 are expected to have beneficial synergies against cancer. Revlimid is also approved for multiple dysplastic syndrome ...
http://www.genengnews.com/news/bnitem.aspx?name=68851356...
|
More Than 200 Abstracts Evaluating Celgene Products across a Range ...
11 Nov 2009 ... SUMMIT, NJ--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG - News) today announced that clinical investigators from leading hematology ...
http://biz.yahoo.com/bw/091111/20091111005474.html?.v=1...
|
Thalidomide (celgene corp).
Thalidomide, in development by Celgene, inhibits the effects of elevated TNFalpha and may consequently be of use in a range of diseases including
cachexia, ...
http://www.ncbi.nlm.nih.gov/pubmed/18465584...
|
BioSpace - Celgene Corporation News, Search Jobs, Events
Celgene Corporation is delivering the promise of science to patients and their families facing extraordinary challenges with cancer and inflammatory disease
...
http://www.biospace.com/company_profile.aspx?CompanyId=72802...
|
CC-5013 (Celgene).
Celgene, in collaboration with the National Cancer Institute, is developing CC- 5013, the lead compound in a series of thalidomide derivatives that inhibit ...
http://www.ncbi.nlm.nih.gov/pubmed/15242253...
|
|
